Handelsbanken Fonder Ab Biolife Solutions Inc Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$17.67 - $26.07 $58,311 - $86,031	3,300 Added 13.47%	27,800 $605,000
Q4 2022 Feb 07, 2023	BUY	$16.95 - $25.07 $415,275 - $614,215	24,500 New	24,500 $446,000
Q1 2022 May 11, 2022	SELL	$20.81 - $37.29 $143,589 - $257,301	-6,900 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$32.99 - $58.55 $227,631 - $403,995	6,900 New	6,900 $257,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.17B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.